EDGe Surgical, Inc. is thrilled to announce the successful raising of $1,300,000 in funding, marking a significant milestone in our journey to revolutionize orthopedic surgical instrumentation. As a privately held medical device company, EDGe Surgical is dedicated to integrating cutting-edge digital technology with innovative design to set a new standard in orthopedic surgery. Our mission is to deliver advanced solutions that not only improve patient outcomes but also reduce overall healthcare system costs. With this newly secured capital, we are poised to accelerate the development and market deployment of our groundbreaking products, including our flagship innovation, the EDG® Ortho 65.
The EDG® Ortho 65 represents a pioneering advancement in surgical precision, being the first and only single-use electronic depth gauge engineered to accurately measure and safely place orthopedic surgical screws. By incorporating advanced electronic measurement capabilities, the device enhances surgical accuracy while simultaneously mitigating bioburden contamination—a critical factor in preventing surgical site infections. This innovation stands to make a substantial impact in the fields of orthopedic trauma and spine surgery, providing healthcare professionals with the reliable tools they need in their operations.
The funding we have raised will directly support the continued development and rigorous testing of our products, as well as expand our reach within the surgical community. As an active member of both MATTER and the iBIO Institute PROPEL Center, EDGe Surgical is uniquely positioned to leverage collaboration and industry insights to drive further innovation. We are excited to embark on this new chapter and remain committed to delivering precision, reliability, and significant advancements that ultimately benefit both patients and the healthcare community at large.
